Supernus Pharmaceuticals, Inc. (SUPN)

51.45 +2.26 (+4.59%) USD  |  NASDAQ  |  May 06, 16:00
51.07 -0.38 (-0.74%) Pre-Market: 08:25
More

Supernus Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Biogen, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Oncotelic Therapeutics, Inc. Upgrade